ARTICLE | Company News
Morphotek, Baxter Healthcare Corp. deal
August 16, 2004 7:00 AM UTC
BAX will manufacture Morphotek's MORAb-003 cancer antibody, which targets an undisclosed glycoprotein that is overexpressed in about 90% of ovarian tumors. The antibody is in preclinical development ...